rss
Br J Ophthalmol doi:10.1136/bjo.2007.123190

Interleukin 8 promoter polymorphism -251A/T is a risk factor for age related macular degeneration.

  1. Srini V Goverdhan (sg5{at}soton.ac.uk),
  2. Sarah Ennis,
  3. S R Hannan,
  4. K C Madhusudhana,
  5. A J Cree,
  6. A J Luff,
  7. Andrew J Lotery (a.j.lotery{at}soton.ac.uk)
  1. Clinical Neurosciences Division, United Kingdom
  2. Clinical Neurosciences Division, United Kingdom
  3. Southampton Eye Unit, United Kingdom
  4. Southampton Eye Unit, United Kingdom
  5. Clinical Neurosciences Division, United Kingdom
  6. Southampton Eye Unit, United Kingdom
  7. Southampton Eye Unit, United Kingdom
    • Published Online First 29 February 2008

    Abstract

    Background/aims: To determine whether four expression-related cytokine polymorphisms are associated with age related macular degeneration (AMD).

    Methods: DNA from 478 cases with AMD and 555 normal controls was genotyped for the pro-inflammatory IL 1β -511C/T, IL 6 -174C/G, IL 8 -251A/T and anti-inflammatory IL 10 -1082G/A cytokine polymorphisms using the 5' nuclease Taqman assay for allelic discrimination. Associations with AMD were analysed using allelic frequencies.

    Results: The -251A allele of the IL 8 promoter gene polymorphism was more prevalent in AMD patients than controls (P=0.037, OR=1.21, 95% CI=1.01-1.44). Adjusting for age, sex, body mass index (BMI), current smoking and past smoking status did not alter the AMD association significantly (PC= 0.043, OR=1.23, 95% CI=1.0 to 1.50).

    Conclusion: The pro-inflammatory homozygous IL 8 -251AA genotype is an important risk factor for AMD. This may have implications for future therapy with biological agents that could target this cytokine.

    Relevant Article

    • Editorial:Inflammation in the pathogenesis of age-related macular degeneration
      • Atsuhiro Kanda,
      • Goncalo Abecasis,
      • Anand Swaroop
      Br J Ophthalmol 2008;92:448-450doi:10.1136/bjo.2007.131581

    This Article

    1. Abstract
    2. PDF
    3. All versions of this article:
      1. bjo.2007.123190v1
      2. 92/4/537most recent

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.